Frusemide-induced nephrocalcinosis in very low birth weight infants.
Three very low birth weight infants, treated with frusemide for broncho-pulmonary dysplasia are described. They all developed medullary nephrocalcinosis identifiable by real time ultrasound. The sonographic findings of diffuse medullary hyper-echogenicity appears to be specific for nephrocalcinosis.
Kenney
I J
IJ
Royal Alexandra Hospital for Sick Children, Brighton, England.
Aiken
C G
CG
Lenney
W
W
D001997:Bronchopulmonary Dysplasia / Q000188:drug therapy; D005260:Female; D005665:Furosemide / Q000009:adverse effects*; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D008297:Male; D009397:Nephrocalcinosis / Q000139:chemically induced* / Q000175:diagnosis; D014463:Ultrasonography
D005665:Furosemide